Home » Reports » Broker Ratings » GlaxoSmithKline plc 7.8% Potential Upside Indicated by Deutsche Bank
broker ratings

GlaxoSmithKline plc 7.8% Potential Upside Indicated by Deutsche Bank

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘HOLD’ this morning by analysts at Deutsche Bank. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set their target price at 1440 GBX on its stock. This is indicating the analyst believes there is a potential upside of 7.8% from today’s opening price of 1336 GBX. Over the last 30 and 90 trading days the company share price has increased 21.5 points and decreased 181 points respectively. The 52 week high for the share price is currently at 1724.5 GBX while the year low stock price is currently 1270 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,327.27 GBX and a 200 day moving average of 1,518.60. There are currently 4,957,898,573 shares in issue with the average daily volume traded being 8,498,050. Market capitalisation for LON:GSK is £65,920,218,216 GBP.